Haemopoietic growth factor tyrosine kinase receptor expression profiles in normal haemopoiesis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 1996-08 ,pp. : 236-241

John Wiley & Sons Inc

Access to resources Recommend Favorite

The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancer

By  

CANCER, Vol. 121, Iss. 8, 2015-04 ,pp. : E1-E6

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor

By  

CANCER, Vol. 119, Iss. 24, 2013-12 ,pp. : 4325-4332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Should Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Be Continued beyond Progressive Disease

By  

Case Reports in Oncology, Vol. 4, Iss. 3, 2011-09 ,pp. : 470-474

Karger

Access to resources Recommend Favorite

Diabetes-Induced Renal Vascular Dysfunction Is Normalized by Inhibition of Epidermal Growth Factor Receptor Tyrosine Kinase

By  

Journal of Vascular Research, Vol. 42, Iss. 4, 2005-07 ,pp. : 284-291

Karger

Access to resources Recommend Favorite